Dr. Andrei Iagaru, MD
Claim this profileStanford University
Area of expertise
Prostate Cancer
Andrei Iagaru, MD has run 5 trials for Prostate Cancer. Some of their research focus areas include:
Pancreatic Cancer
Andrei Iagaru, MD has run 3 trials for Pancreatic Cancer. Some of their research focus areas include:
Affiliated Hospitals
Stanford University
Stanford University School Of Medicine
Clinical Trials Andrei Iagaru, MD is currently running
[225Ac]-FPI-2068
for Cancer
This is a first-in-human, Phase 1, non-randomized, multicenter, open-label clinical study designed to investigate the safety, tolerability, dosimetry, biodistribution, and pharmacokinetics (PK) of \[225Ac\]-FPI-2068, \[111In\]-FPI-2107, and FPI-2053 in metastatic and/or recurrent solid tumors (HNSCC, NSCLC, mCRC, PDAC, GC, RCC).
Recruiting
1 award
Phase 1
6 criteria
[225Ac]Ac-FL-020
for Prostate Cancer
The purpose of this study is to evaluate the safety, therapeutic effect, and pharmacokinetics of \[225Ac\]Ac-FL-020 in participants with metastatic castration-resistant prostate cancer (mCRPC).
Recruiting
1 award
Phase 1
8 criteria
More about Andrei Iagaru, MD
Clinical Trial Related
1 year of experience running clinical trials · Led 15 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Andrei Iagaru, MD has experience with
- Gallium Ga 68-labeled GRPR Antagonist BAY86-7548
- [18F]FP-R01-MG-F2
- 18F-C-SNAT4
- FPI-2053
- [225Ac]-FPI-2068
- [111In]-FPI-2107
Breakdown of trials Andrei Iagaru, MD has run
Prostate Cancer
Pancreatic Cancer
Prostate Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrei Iagaru, MD specialize in?
Andrei Iagaru, MD focuses on Prostate Cancer and Pancreatic Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Andrei Iagaru, MD currently recruiting for clinical trials?
Yes, Andrei Iagaru, MD is currently recruiting for 3 clinical trials in Stanford California. If you're interested in participating, you should apply.
Are there any treatments that Andrei Iagaru, MD has studied deeply?
Yes, Andrei Iagaru, MD has studied treatments such as Gallium Ga 68-labeled GRPR Antagonist BAY86-7548, [18F]FP-R01-MG-F2, 18F-C-SNAT4.
What is the best way to schedule an appointment with Andrei Iagaru, MD?
Apply for one of the trials that Andrei Iagaru, MD is conducting.
What is the office address of Andrei Iagaru, MD?
The office of Andrei Iagaru, MD is located at: Stanford University, Stanford, California 94304 United States. This is the address for their practice at the Stanford University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.